Edition:
United States

Astellas Pharma Canada Says Health Canada Approved Expanded Indication For Xtandi


Monday, 14 Jan 2019 08:00am EST 

Jan 14 (Reuters) - Astellas Pharma Inc <4503.T>::ASTELLAS PHARMA CANADA - HEALTH CANADA APPROVED EXPANDED INDICATION FOR XTANDI (ENZALUTAMIDE), FOR TREATMENT OF PATIENTS WITH PROSTATE CANCER.ASTELLAS PHARMA CANADA - XTANDI (ENZALUTAMIDE) IS NOW INDICATED TO TREAT MEN WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER.